Compare OMF & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMF | RGEN |
|---|---|---|
| Founded | 1920 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 8.2B |
| IPO Year | 2013 | N/A |
| Metric | OMF | RGEN |
|---|---|---|
| Price | $64.07 | $168.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $68.23 | ★ $177.18 |
| AVG Volume (30 Days) | ★ 1.0M | 588.4K |
| Earning Date | 02-05-2026 | 02-19-2026 |
| Dividend Yield | ★ 6.61% | N/A |
| EPS Growth | ★ 29.36 | N/A |
| EPS | ★ 5.90 | 0.03 |
| Revenue | ★ $2,892,000,000.00 | $707,890,000.00 |
| Revenue This Year | $72.81 | $17.86 |
| Revenue Next Year | $8.39 | $12.44 |
| P/E Ratio | ★ $10.77 | $6,418.69 |
| Revenue Growth | ★ 16.10 | 11.74 |
| 52 Week Low | $38.00 | $102.97 |
| 52 Week High | $71.93 | $182.52 |
| Indicator | OMF | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 58.01 |
| Support Level | $63.24 | $157.29 |
| Resistance Level | $71.93 | $172.51 |
| Average True Range (ATR) | 1.70 | 6.42 |
| MACD | -0.92 | -0.42 |
| Stochastic Oscillator | 8.98 | 64.56 |
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.